Table 2 Impact of clofarabine on patients with a high MRD (N=8)
| MRD evolution | Number (%) |
|---|---|
| Improvement of one logarithm | 1 (12.5%) |
| Improvement of less than one logarithm | 3 (37.5%) |
| Stable | 3 (37.5%) |
| Non evaluable | 1 (12.5%) |
| MRD evolution | Number (%) |
|---|---|
| Improvement of one logarithm | 1 (12.5%) |
| Improvement of less than one logarithm | 3 (37.5%) |
| Stable | 3 (37.5%) |
| Non evaluable | 1 (12.5%) |